Thomas Knappe
Inventor
Stats
- 1 US patents issued
- 15 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 1 US Patents Issued
- 15 US Applications Filed
- 41 Total Citation Count
- Mar 27, 2023 Most Recent Filing
- Oct 11, 2012 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| ASCENDIS PHARMA OPHTHALMOLOGY DIVISION A/S | 1
1 | 2012
2013 |
| Ascendis Pharma Ophthamology Division A/S | 1
1 | 2012
2017 |
| ASCENDIS PHARMA A/S | 2
2 1 | 2013
2014 2015 |
Inventor Addresses
| Address | Duration |
|---|---|
| Dossenheim, DE | Aug 10, 17 - Aug 10, 17 |
| Heidelberg, DE | Jan 08, 15 - Mar 11, 25 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 14 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 2 |
| C07K: | PEPTIDES | 5 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 12246070 | 2025 | Hydrogel cross-linked hyaluronic acid prodrug compositions and methods | 0 |
| 2023/0414,770 | 2023 | HYDROGEL CROSS-LINKED HYALURONIC ACID PRODRUG COMPOSITIONS AND METHODS | 0 |
| 2023/0340,055 | 2023 | GLYCOSYLATED IL-2 PROTEINS AND USES THEREOF | 0 |
| 2023/0116,809 | 2023 | PREVENTION AND TREATMENT OF OCULAR CONDITIONS | 0 |
| 2022/0305,136 | 2022 | ANTI-CTLA4 CONJUGATES | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.